Rinvoq ER 15 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB25FG4AC
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,290
Award facts
- Contract value 100% obligated
- $10,290.23 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count units) valued at $10,290.23 with a firm fixed price structure. This non-set-aside, competitively awarded contract was executed on June 2, 2025, with an ultimate completion date of June 3, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. RINVOQ (upadacitinib) is a Janus kinase (JAK) inhibitor used to treat rheumatoid arthritis and other inflammatory conditions, representing part of the pharmaceutical supply chain supporting military and federal healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999.99 billion through December 2026. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen supplies a broad portfolio of brand-name and generic medications, vaccines, and medical supplies to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems worldwide. The company's consistent receipt of competitive delivery orders demonstrates its capability to meet federal procurement requirements across diverse therapeutic domains and transaction volumes.
Quick answers
Who was awarded contract SPE2DB25FG4AC?
SPE2DB25FG4AC was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 2, 2025.
How much is contract SPE2DB25FG4AC worth?
The government has obligated $10,290 on SPE2DB25FG4AC.
Is contract SPE2DB25FG4AC an order under another contract?
Yes. SPE2DB25FG4AC is a delivery order under SPE2DB22D1017, an indefinite delivery contract.
Was contract SPE2DB25FG4AC competed?
The extent of competition for SPE2DB25FG4AC was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award